Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Clean Power Hydrogen PLC ( (GB:CPH2) ) has issued an announcement.
Clean Power Hydrogen PLC has signed a non-binding memorandum of understanding with Koch Modular Process Systems to explore manufacturing and licensing of its Membrane-Free Electrolyser technology in North America. Koch Modular, a subsidiary of Koch Industries based in New Jersey and Texas, designs and manufactures modular mass transfer systems for the chemical process industry.
The 24‑month MoU sets a framework to assess technical, commercial and operational feasibility, including supply chain localisation, with the goal of moving to a binding agreement covering up to 100 MW of CPH2’s modular hydrogen systems for Mexico, the U.S. and Canada. If formalised, the partnership would give CPH2 a significant route to market in North America, leveraging Koch Modular’s engineering and manufacturing capabilities to scale deployment of its patented hydrogen technology across the region.
The most recent analyst rating on (GB:CPH2) stock is a Hold with a £4.50 price target. To see the full list of analyst forecasts on Clean Power Hydrogen PLC stock, see the GB:CPH2 Stock Forecast page.
Spark’s Take on CPH2 Stock
According to Spark, TipRanks’ AI Analyst, CPH2 is a Neutral.
The score is held down primarily by very weak financial performance (near-zero revenue, widening losses, and significant cash burn with a sharply reduced equity base). Technicals are moderately supportive with an uptrend and positive momentum, but elevated RSI increases pullback risk. Valuation remains unattractive/unclear due to ongoing losses and no indicated dividend yield.
To see Spark’s full report on CPH2 stock, click here.
More about Clean Power Hydrogen PLC
Clean Power Hydrogen PLC, listed on London’s AIM market as CPH2, develops proprietary Membrane-Free Electrolyser technology that produces high-purity hydrogen and above medical-grade oxygen. The company targets decentralised hydrogen markets, including wastewater treatment, curtailed wind power capture, data centre backup, medical and life sciences, and heavy-duty mobility applications.
Backed by a decade of research and global patents, CPH2 aims to deliver the lowest lifetime levelised cost of hydrogen to support growing clean energy demand. Its modular systems are designed to lower operating costs and improve reliability for distributed industrial and infrastructure users seeking low-carbon fuel and oxygen solutions.
Average Trading Volume: 501,235
Technical Sentiment Signal: Buy
Current Market Cap: £30.12M
Find detailed analytics on CPH2 stock on TipRanks’ Stock Analysis page.

